Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), bought 10,000 shares at $5.38 ($54K) on 2023-05-15, disclosed to the SEC on 2023-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ANTX | SELL | 2024-01-04 | $112K | — | Filing → |
| ANTX | SELL | 2022-11-14 | $136K | — | Filing → |
| ANTX | SELL | 2022-11-09 | $426K | — | Filing → |